` YMAB (Y-mAbs Therapeutics Inc) vs ABBV (Abbvie Inc) Comparison - Alpha Spread

YMAB
vs
ABBV

Over the past 12 months, YMAB has underperformed ABBV, delivering a return of -63% compared to the ABBV's +15% growth.

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
YMAB
ABBV
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Valuation
Growth
Profitability
Solvency
Comparing Valuation
Running a multi-layered valuation analysis to compare how attractive each stock is.
Comparing Growth
Financial growth, forecasts, volatility, and historical drawdowns.
Comparing Profitability
Margins, returns on capital, and the consistency of profitability.
Comparing Solvency
Debt levels, liquidity, interest coverage, and bankruptcy risk.
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

YMAB Intrinsic Value
9 USD
Undervaluation 53%
Intrinsic Value
Price
ABBV Intrinsic Value
164.55 USD
Overvaluation 13%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Y-mAbs Therapeutics Inc
NASDAQ:YMAB
4.26 USD
Abbvie Inc
NYSE:ABBV
189.28 USD
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
YMAB vs ABBV

YMAB
ABBV
Add Stock
Revenue
www.alphaspread.com
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Y-mAbs Therapeutics Inc
Revenue
Abbvie Inc
Revenue

All metrics are calculated based on data from the last 10 years.

Profitability Comparison

Free Cash Flow
YMAB vs ABBV

YMAB
ABBV
Add Stock
Free Cash Flow
www.alphaspread.com
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Y-mAbs Therapeutics Inc
NASDAQ:YMAB
Abbvie Inc
NYSE:ABBV
What is Free Cash Flow?

Gross Margin

YMAB
82.1%
ABBV
70.7%
LTM 3Y Avg 5Y Avg 10Y Avg
Y-mAbs Therapeutics Inc
Abbvie Inc

Operating Margin

YMAB
-34.8%
ABBV
30.4%
LTM 3Y Avg 5Y Avg 10Y Avg
Y-mAbs Therapeutics Inc
Abbvie Inc

Net Margin

YMAB
-31.8%
ABBV
7.2%
LTM 3Y Avg 5Y Avg 10Y Avg
Y-mAbs Therapeutics Inc
Abbvie Inc

FCF Margin

YMAB
-21.7%
ABBV
26.8%
LTM 3Y Avg 5Y Avg 10Y Avg
Y-mAbs Therapeutics Inc
Abbvie Inc

ROE

YMAB
-29.9%
ABBV
88.2%
LTM 3Y Avg 5Y Avg 10Y Avg
Y-mAbs Therapeutics Inc
Abbvie Inc

ROA

YMAB
-23.9%
ABBV
2.9%
LTM 3Y Avg 5Y Avg 10Y Avg
Y-mAbs Therapeutics Inc
Abbvie Inc

ROIC

YMAB
-68.9%
ABBV
20.3%
LTM 3Y Avg 5Y Avg 10Y Avg
Y-mAbs Therapeutics Inc
Abbvie Inc

ROCE

YMAB
-30.9%
ABBV
16.9%
LTM 3Y Avg 5Y Avg 10Y Avg
Y-mAbs Therapeutics Inc
Abbvie Inc

Solvency Comparison

Balance Sheet Comparison

Stocks Performance

Stocks Performance
YMAB vs ABBV

Loading

Performance Gap
YMAB vs ABBV

Loading
YMAB
ABBV
Difference
www.alphaspread.com

Performance By Year
YMAB vs ABBV

Loading
YMAB
ABBV
Add Stock
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare YMAB to other stocks
Unlock Full Access to Alpha Spread
Create Free Account